[Event Report] The 52nd Special Breakfast Meeting – US-China Competition and Healthcare Industry: New Frontier of Economic Security (October 23, 2023)
date : 2/2/2024
For the 52nd Special Breakfast Meeting, we hosted Mr. Kurt Tong (Managing Director, The Asia Group). Based on his experience as a career diplomat and senior foreign affairs officer with the US Department of State for over 30 years and his current role as Managing Director of The Asia Group, Mr. Tong spoke about the intricate geopolitical dynamics between the US, China, and Japan at the intersection of regional security, health care, and economics.
Key points of the lecture:
- US and China are in a “quasi Cold War” with economic interdependence and military wariness. While cooperation is stagnant, neither desires open conflict. US-China relations declined in 2023 due to the balloon incident, Pelosi’s Taiwan visit, and trade restrictions. The upcoming Biden-Xi meeting will address sensitive topics like Taiwan.
- More economically dependent on China, Japan adopts a cautious approach compared to the US, including avoiding tariffs and Taiwan conflict.
- Frequent communication and minimal economic friction mark the strong US-Japan relationship, allowing for collaboration on various challenges.
- Japan’s system disincentivizes innovation and new entrants. Policy reforms are needed to revitalize the sector.
- Due to the complex geopolitical situation, US government intervention in Japan’s pharma industry is limited. Moreover, trade restrictions, unfair competition, and data flow issues pose challenges in the Chinese pharmaceutical space.
“Bad but stable” US-China Relations
The US and China exist in a tense “quasi Cold War” where economic interdependence is intertwined with military wariness. Neither desires open conflict, but cooperation remains stagnant. The US strategy bets on isolating China to hinder its growth, while China anticipates internal US strife leading to its decline. Japan’s “Free and Open Indo-Pacific(FOIP)” aims to establish a rules-based order for China to eventually accept. This approach is exemplified by significant trade ties like Apple and Tesla’s reliance on Chinese manufacturing, the contested South China Sea where US-China military exercises highlight friction, US tariffs and technology export restrictions as part of their strategy, and China’s retaliatory tariffs and anti-US propaganda campaigns showcasing their response.
Fall Marked by Missed US-China Opportunities
The first half of 2023 saw a decline in US-China relations, punctuated by the balloon incident and Pelosi’s visit to Taiwan. Efforts to repair this damaged relationship culminate in a November 2023 Biden-Xi meeting tackling sensitive topics like Taiwan, where compromise remains elusive. The decline was exacerbated by the US shooting down a Chinese “spy balloon” leading to China sanctioning US defense contractors. The upcoming Biden-Xi meeting at the Asia-Pacific Economic Cooperation (APEC) Leaders’ Summit in San Francisco will focus on economic issues, climate change, and Taiwan, highlighting the sensitivity of the latter topic where Taiwan, self-governed yet claimed by China, faces potential military unification threats.
Divergences on China in US-Japan Relationship
Compared to the US, Japan’s heavier economic dependence on China fosters a more cautious approach. This is evident in their over 20% trade dependence on China and their reluctance to join US tariffs on China. Japan’s policy consistency contrasts with US fluctuations due to political shifts, and their geographical proximity to Taiwan makes them acutely aware of potential conflict arising from that issue. Unlike the US sending warships near Taiwan, Japan has abstained, showcasing their contrasting policies.
US-Japan Ties Strengthen Amid Pressures
Excellent communication and minimal economic friction characterize US-Japan relations. Regular summits and cabinet-level meetings solidify strong communication, and a bilateral trade agreement reduces tariffs on numerous goods, minimizing economic friction. This strong relationship allows for collaboration on various challenges, including those posed by China, Russia, and the Middle East, exemplifying their joint efforts to counter China’s influence in the Indo-Pacific region.
TAG White Paper on Pharma Policy
The Asia Group’s White Paper on Pharma Policy identifies critical challenges hindering Japan’s pharmaceutical industry and proposes solutions to revitalize this sector. Additionally, the fee-for-service payment method and social security system, which offer little incentive for medical providers to improve efficiency in healthcare delivery and for individuals to engage in prevention, focus on controlling drug prices while also leading to the suppression of innovation and investment. This, coupled with two specific pricing policies – the “co-factor zero” rule and the Price Maintenance Premium system’s corporate status criteria – further disadvantages new entrants and foreign companies, restricting access to novel drugs. The paper urges the Japanese government to eliminate these “low-hanging fruit” policies to stimulate innovation and attract new players, ultimately benefiting patients. While acknowledging the complex geopolitical situation with China and limited potential for US government intervention, the paper suggests possible support from US industry and academia. However, it also anticipates increasing difficulties in the Chinese pharmaceutical space due to trade restrictions, unfair competition, and data flow issues. In essence, the paper calls for targeted policy reforms in Japan to foster a more vibrant and innovative pharmaceutical sector, while navigating the broader geopolitical landscape and its impact on the industry.
(Photographed by: Kazunori Izawa)
■Speaker Profile
Mr. Kurt Tong (Managing Partner, The Asia Group)
Mr. Kurt Tong is a Managing Partner and member of the Executive Committee at The Asia Group, where he leads consulting teams focused on Japan, China and Hong Kong, and on East Asia regional policy matters. He also leads the firm’s innovative thought leadership programs. A leading expert in diplomacy and economic affairs in East Asia, Mr. Tong brings thirty years of experience in the Department of State as a career Foreign Service Officer and member of the Senior Foreign Service.
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
Featured Posts
-
2024-10-28
[Registration Open] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)
-
2024-11-01
[Registration Open] Designing for Dementia Briefing Session 2024 – Conversations on the Trajectory of Our Activities and Envisioning the Future (December 3, 2024)
-
2024-11-11
[Discussion Points] Women’s Health Project Expert Meeting “The Ideal System for Perinatal Medical Care in Japan in the Era of Declining Birth Rates” (November 11, 2024)
-
2024-11-11
[Registration Open] (Hybrid Format) Obesity Control Promotion Project Public Symposium “Obesity Control as a Social Issue; Toward the Realization of Citizen-Centered Policies” (December 4, 2024)
-
2024-11-14
[Reserch Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)